BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 49 found
  Current Search:  mol: 49     

HTML
100%
Transgenic wheat has increased polyamines
Crop productivity relies heavily on abundant supplies of water for irrigation.

Although drought and salt tolerance genes are present in wheat, breeding for stress tolerance is time- and labour-intensive and complicated by the multigenic...

Checkbiotech:  Jul 3 2008 7:57AM
Matching: mol
Find similar documents
HTML
100%
Hot paper in Gene Expression: Caution: RNAi
Biophoto Associates / Photo Researchers, Inc.

Grimm et al., 'Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways,' Nature, 441:537-41, 2006.

(Cited in 147 papers) While studying the potential of RNA...

The Scientist:  Jul 2 2008 11:13PM
Matching: mol
Find similar documents
HTML
100%
Calcium Deposits and Heart Disease
Prof.

Joe Cumminsspeaks on a health issue closest to his heart Public education versus personal case notes The Framingham health study has been following the health of residents in the Massachusetts town in the United States since 1948 and...

Institute of Sciences in Society:  Jul 2 2008 7:46PM
Matching: mol
Find similar documents
HTML
100%
TopAbstracts in Alzheimer's 06/26/2008
TopAbstracts in Alzheimer's are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 14 days.

Over 2000 peer-reviewed...

Doctors Guide:  Jun 28 2008 1:30AM
Matching: mol
Find similar documents
HTML
100%
Handle with care
Last Autumn, I stowed away at the UK's Primary Care Diabetes Society conference.

I wanted to know more about the disease that, according to the 2002 report by Sir Derek Wanless, threatens to bankrupt the UK's National Health Service (NHS)...

Lancet:  Jun 27 2008 3:18AM
Matching: mol
Find similar documents
HTML
100%
Mice Expressing Human Genes Bred to Help Unravel Mental Disorders
New mouse strains engineered to express human genes related to mental disorders are being developed under a recently-launched grant program from NIMHs Division of Neuroscience and Basic Behavioral Science.

The new models are designed to...

NIMH:  Jun 27 2008 8:35PM
Matching: mol
Find similar documents
HTML
100%
Immune-Based Therapy With Glatiramer Acetate for Dry AMD
GENNADY LANDA, MD OLEG BUTOVSKY, PhD JOHAI SHOSHANI, MD MICHAL SCHWARTZ, PhD AYALA POLLACK, MD Age-related macular degeneration (AMD) and Alzheimer's disease (AD) are chronic neurodegenerative diseases that are strongly associated with...
Retinal Physician:  Jun 15 2008 8:11PM
Matching: mol
Find similar documents
HTML
100%
Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis
Data Suggest Role of Hemolysis in PNH-Related Fatigue CHESHIRE, Conn., June 15 /PRNewswire-FirstCall/ -- Soliris(R) (eculizumab) therapy improved the often disabling fatigue experienced by patients with the rare blood disorder paroxysmal...
KOTA Territory News:  Jun 15 2008 8:13AM
Matching: mol
Find similar documents
HTML
100%
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
Background In patients with type 2 diabetes, the effects of intensive glucose control on vascular outcomes remain uncertain.

Methods We randomly assigned 11,140 patients with type 2 diabetes to undergo either standard glucose control or...

National AIDS Treatment Advocacy Project:  Jun 12 2008 8:56PM
Matching: mol
Find similar documents
HTML
100%
Reframing ADHD in the Genomic Era
The Emerging View of ADHD in the 21st Century: More Complex Than Previously Believed.

In the era of genomics, psychiatrylike all areas of medicinewill likely undergo radical change.

As genetic risk factors are uncovered and the dynamic...

Consultant Live:  Jun 11 2008 4:13PM
Matching: mol
Find similar documents
HTML
100%
Frontiers in Psychiatric Research
Dr Wong is Miller Professor and vice-chair for translational research and Dr Arcos-Burgos is research associate professor in the department of psychiatry and behavioral sciences at the Leonard M.

Miller School of Medicine, University of...

Consultant Live:  Jun 11 2008 7:08PM
Matching: mol
Find similar documents
HTML
100%
Effects of Intensive Glucose Lowering in Type 2 Diabetes
The Action to Control Cardiovascular Risk in Diabetes Study Group ABSTRACT Background Epidemiologic studies have shown a relationship between glycated hemoglobin levels and cardiovascular events in patients with type 2 diabetes.

We...

National AIDS Treatment Advocacy Project:  Jun 11 2008 8:47PM
Matching: mol
Find similar documents
HTML
100%
Lipoxygenase identified as possible target for asthma therapy
Am J Respir Cell Mol Biol 2008; Advance online publication MedWire News: Mice deficient in 15-lipoxygenase (LO)-1 do not establish fully developed allergic airway inflammation despite having fully developed systemic sensitization,...
MedWire News:  Jun 9 2008 3:40AM
Matching: mol
Find similar documents
HTML
100%
Airway inflammation induced by NTHi exposure
Am J Respir Cell Mol Biol 2008; 38: 629-638 MedWire News: Aspects of chronic obstructive pulmonary disease (COPD) can be induced by repetitive exposure to nontypeable Haemophilus influenzae (NTHi), according to US researchers.

The...

MedWire News:  Jun 6 2008 12:30AM
Matching: mol
Find similar documents
HTML
100%
The Opioid System and Antidepressant Response: How the Opioid System Affects Response to Psychophary
The -Opioid System and Antidepressant Response How the Opioid System Affects Response to Psychopharmacology This article discusses the role of -opioid receptors (MORs) in antidepressant treatment and major depressive disorder (MDD).
Consultant Live:  Jun 5 2008 2:10AM
Matching: mol
Find similar documents
HTML
100%
New Positive Data Announced for NKTR-102 (PEG-irinotecan), Highlights Promise of Nektar's Innovative Small Mol
SAN CARLOS, Calif., June 2 /PRNewswire-FirstCall/ -- Nektar Therapeutics announced new positive data today from a Phase 1 clinical study for NKTR-102 (PEG-irinotecan) in advanced cancer patients whose tumors had progressed on other therapies...
KOTA Territory News:  Jun 2 2008 3:44PM
Matching: mol
Find similar documents
HTML
100%
New Positive Data Announced for NKTR-102 (PEG-irinotecan), Highlights Promise of Nektar's Innovative Small Mol
/PRNewswire-FirstCall/ -- Nektar Therapeutics announced new positive data today from a Phase 1 clinical study for NKTR-102 (PEG-irinotecan) in advanced cancer patients whose tumors had progressed on other therapies.

Significant anti-tumor...

Pharma Live:  Jun 2 2008 1:48PM
Matching: mol
Find similar documents
HTML
100%
New Positive Data Announced for NKTR-102 (PEG-irinotecan), Highlights Promise of Nektar's Innovative Small Mol
SAN CARLOS, Calif., June 2 /PRNewswire-FirstCall/ -- Nektar Therapeutics announced new positive data today from a Phase 1 clinical study for NKTR-102 (PEG-irinotecan) in advanced cancer patients whose tumors had progressed on other therapies...
Therapeutics Daily:  Jun 2 2008 1:05PM
Matching: mol
Find similar documents
HTML
100%
New Positive Data Announced for NKTR-102 (PEG-irinotecan), Highlights Promise of Nektar's Innovative Small Mol
SAN CARLOS, Calif., June 2 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) announced new positive data today from a Phase 1 clinical study for NKTR-102 (PEG-irinotecan) in advanced cancer patients whose tumors had progressed on...
Calibre Macro World:  Jun 2 2008 12:46PM
Matching: mol
Find similar documents
HTML
100%
Diabetes treatments: from supplements to foods
New research findings into traditional supplemental ingredients are driving new applications for diabetes health.

Food formulators are taking note, and incorporating GRAS-approved ingredients into their offerings, and also utilising better...

Functional Foods & Nutraceuticals:  Jun 1 2008 5:59AM
Matching: mol
Find similar documents
HTML
100%
New Data Offers Insights Into the Potential Role for TYKERB(R)
/PRNewswire-FirstCall via COMTEX/ -- GlaxoSmithKline today announced the results of three studies evaluating TYKERB -- an oral, small molecule inhibitor of HER2 -- in various breast cancer settings, either in combination with other targeted...
Excite Money & Investing:  Jun 1 2008 7:18PM
Matching: mol
Find similar documents
HTML
100%
New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based
LONDON, and PHILADELPHIA, June 1 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced the results of three studies evaluating TYKERB -- an oral, small molecule inhibitor of HER2 -- in various breast cancer settings, either in...
SmartBrief:  Jun 1 2008 4:27PM
Matching: mol
Find similar documents
HTML
100%
New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based
LONDON, and PHILADELPHIA, June 1 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced the results of three studies evaluating TYKERB -- an oral, small molecule inhibitor of HER2 -- in various breast cancer settings, either in...
Forbes.com:  Jun 1 2008 1:28PM
Matching: mol
Find similar documents
HTML
100%
New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based
LONDON, and PHILADELPHIA, June 1 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced the results of three studies evaluating TYKERB -- an oral, small molecule inhibitor of HER2 -- in various breast cancer settings, either in...
Calibre Macro World:  Jun 1 2008 1:03PM
Matching: mol
Find similar documents
HTML
100%
Research and Markets: Cytokinetics is the First Company to Systematically Investigate the Cytoskeleton and Mol
- Research and Markets (http://www.researchandmarkets.com/reports/c93056) has announced the addition of 'Cytokinetics Inc: Premium Company Profile' to their offering.

Cytokinetics is the first company to systematically investigate the...

Pharma Live:  May 29 2008 12:32AM
Matching: mol
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.